Partnering with Tokyo University of Agriculture and Technology (TUAT), World Bank HEAT, Bangladesh MOHFW, and BFRI to advance viral disease diagnostics, therapeutics, and translational biotechnology.
Explore our key research agreements, joint laboratories, and grant allocations.
Long-standing bilateral research collaboration focusing on structural immunology, protein engineering, NMR spectroscopy, X-ray crystallography, and novel peptide solubility tags.
Flagship institutional grant empowering advanced vaccine research, genomics infrastructure, and state-of-the-art flow cytometry and molecular biology facilities at MSI Lab.
Partnership for epidemiology surveillance, regional clinical sample coordination, and rapid COVID-19 molecular testing leadership during national emergency responses.
Continuous research grant provider supporting competitive biochemical investigations, student R&D fellowships, and reagent procurement for vaccine research.
Interdisciplinary collaboration investigating indigenous botanical extracts, secondary metabolites, and natural immunomodulatory compounds with antiviral properties.
Host university core ecosystem providing animal house ethical testing facilities, cell culture suites, autoclave facilities, and cross-departmental biotechnology platforms.
Premier regional tertiary healthcare center collaborating with MSI Lab on clinical cohort bio-specimen acquisition, acute-phase Dengue and Chikungunya patient serum biobanking, and sero-epidemiological tracking.
Specialized healthcare and medical research institution collaborating with MSI Lab on maternal-neonatal sero-epidemiology, pediatric infectious disease immunology, and cutaneous manifestation biomarker profiling.
We welcome research collaborations with universities, biotechnology firms, and clinical institutes interested in recombinant vaccines, monoclonal antibody validation, and structural virology.